Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease

被引：0
作者：
Gao, Xiaoya [1 ,2 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Pediat Neurol, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
来源：
FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 15卷
关键词：
Alzheimer's disease; Parkinson's disease; disease modification; neuroprotection; novel targets; neurodegeneration;
D O I：
10.3389/fnagi.2023.1247256
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页数：3
相关论文
共 5 条
[1]   Parkinson's disease [J].
Bloem, Bastiaan R. ;
Okun, Michael S. ;
Klein, Christine .
LANCET, 2021, 397 (10291) :2284-2303
[2]   Parkinson's disease [J].
Kalia, Lorraine V. ;
Lang, Anthony E. .
LANCET, 2015, 386 (9996) :896-912
[3]   Understanding Dopaminergic Cell Death Pathways in Parkinson Disease [J].
Michel, Patrick P. ;
Hirsch, Etienne C. ;
Hunot, Stephane .
NEURON, 2016, 90 (04) :675-691
[4]   Association between polygenic risk for Alzheimer's disease, brain structure and cognitive abilities in UK Biobank [J].
Tank, Rachana ;
Ward, Joey ;
Flegal, Kristin E. ;
Smith, Daniel J. ;
Bailey, Mark E. S. ;
Cavanagh, Jonathan ;
Lyall, Donald M. .
NEUROPSYCHOPHARMACOLOGY, 2022, 47 (02) :564-569
[5]  
Zhao Y., 2022, FRONT DRUG DISCOV, V2, P983030, DOI [10.3389/fddsv.2022.983030, DOI 10.3389/FDDSV.2022.983030]
1